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Background: There have been few investigations evaluating the burden of malaria disease at district level in the
Republic of Congo since the introduction of artemisinin-based combination therapies (ACTs). The main objective of
this study was to document laboratory-confirmed cases of malaria using microscopy and/or rapid diagnostic tests
(RDTs) in children and pregnant women attending selected health facilities in Brazzaville and Pointe Noire, the two
main cities of the country. Secondly, P. falciparum genetic diversity and multiplicity of infection during the malaria
transmission season of October 2011 to February 2012 in these areas were described.
Methods: Three and one health facilities were selected in Brazzaville and Pointe-Noire as sentinel sites for malaria
surveillance. Children under 15 years of age and pregnant women were enrolled if study criteria were met and lab
technicians used RDT and/or microscopy to diagnose malaria. In order to determine the multiplicity of infection,
parasite DNA was extracted from RDT cassette and msp2 P.falciparum genotyped.
Results: Malaria prevalence among more than 3,000 children and 700 pregnant women ranged from 8 to 29%, and
8 to 24% respectively depending on health center locality. While health workers did not optimize use of RDTs,
microscopy remained a reference diagnostic tool. Quality control of malaria diagnosis at the reference laboratory
showed acceptable health centre performances. P. falciparum genetic diversity determination using msp2 gene
marker ranged from 9 to 20 alleles and remains stable while multiplicity of infection (mean of 1.7clone/infected
individual) and parasite densities in clinical isolates were lower than previously reported.
Conclusions: These findings are consistent with a reduction of malaria transmission in the two areas. This study
raises the issue of targeted training for health workers and sustained availability of RDTs in order to improve quality
of care through optimal use of RDTs.
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of CongoBackground
Deployment of various control tools has boosted malaria
control in sub-Saharan Africa. This includes wide de-
ployment of artemisinin-combination therapies (ACTs),
insecticide-treated nets and in some places targeted in-
door residual spraying (IRS) of insecticides. Conse-
quently, the burden of malaria has declined in some* Correspondence: fntoumi@fcrm-congo.com
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reproduction in any medium, provided the orcountries [1], while other countries were unable to pro-
vide accurate data on their malaria situation.
The World Health Organization (WHO) recommends
parasitological confirmation of malaria using microscopy
or RDTs in all malaria suspected patients before starting
them on anti-malarial treatment [2]. Treatment based
solely on clinical suspicion is warranted when resources
for parasitological diagnosis are not available [2,3]. This
strategy would ensure the therapeutic longevity of ACTs
through protection against development of parasite
resistance.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Republic of Congo since drug policy change in 2002 is
limited, making it difficult to evaluate the impact of
implemented malaria interventions. Malaria remains the
main cause of hospital consultations, accounting for 49
to 51.5% of hospital admissions and 35.4% of children
deaths at health facilities in Brazzaville and Pointe-Noire
districts [4]. Diagnosis of malaria is through microscopy
despite availability of RDTs [5]. At country level, perfor-
mances of laboratory technicians using microscopy or
RDTs are not yet assessed, despite its influence on appli-
cation of guidelines for malaria treatment and subse-
quently on the overall impact on malaria control.
Genetic diversity of Plasmodium falciparum is an im-
portant parameter for malaria surveillance that plays a
major role in the natural acquisition of malaria immun-
ity. Exposure to several strains positively influences the
development of partial immunity to malaria in people
living in malaria endemic areas [6]. Although daily fluc-
tuation of parasite populations does not determine the
true individual multiplicity of infection or the genetic di-
versity of circulating strains [7], the two parameters
allow characterization of malaria infection in human
populations and improves understanding of acquisition
of natural immunity to P. falciparum [6].
From 2009, the Central Africa regional network of excel-
lence on HIV/AIDS, tuberculosis and malaria (CANTAM)
project engaged itself in passive surveillance of malaria at
sentinel sites in Brazzaville and Pointe Noire to provide ne-
cessary baseline data. For this purpose, training activities
included improving malaria diagnostic skills of laboratory
technicians through training together with providing ap-
propriate stocks of RDTs (UNICEF donation) and reagents
for microscopy. As most malaria epidemiological studies
had been conducted in Southern areas of Brazzaville, the
capital of the Republic of Congo [8-10], the main objective
of the present study was to document laboratory-
confirmed cases of malaria in children and pregnant
women attending health facilities in Northern districts of
Brazzaville and one main health district Center in Pointe
Noire, the second largest city of the Republic. Secondarily,
the genetic diversity and multiplicity of P. falciparum was
determined during the malaria transmission period of
October 2011 to February 2012 in these areas. Generated
data will form the basis for monitoring and evaluating the
impact of introduced malaria control tools.Methods
Study sites
Brazzaville, the capital city of Republic of Congo is served
by three health facilities namely: Hospital of Talangai,
Centre de Santé Integré (CSI) Fleuve Congo and CSI
Intendance in the Northern part of Brazzaville that wereselected as sentinel sites for malaria surveillance. CSI
Ndaka Sossou health facility in the center of Pointe-Noire,
a commercial city bordering the Atlantic Ocean was also
selected as a sentinel site. Laboratory technicians were
trained for two days, after which they were allowed to
participate in the study using microscope or RDTs to
diagnose malaria infection. To avoid interference with
routine laboratory work, hospital technicians were not
involved beyond specimen collection, processing and
examination. Patients received antimalarial treatment if
result from at least one of the technique was positive.
Malaria transmission in the study areas varies from low,
moderate to intense with meso- hyper-to perennial endem-
icity. There are two rainy seasons each year, from October
to December and February to May. In the study by Trape
et al. [11], the average entomological inoculation rate (EIR)
in Brazzaville was 0.83 infective bite/man/night, due to
Anopheles gambiae, A. funestus, and A. moucheti.
Ethical clearance
This study was approved by the Institutional Ethics
Committee of the Congolese Foundation for Medical
Research. Written informed consent was given by parti-
cipants or by parents or guardians of children who parti-
cipated in the study.
Patients
Children under 15 years of age were enrolled into the
study if they met the following inclusion criteria: fever (ax-
illary temperature ≥37.5C at presentation or history of
fever within the past 24 hours) and without concomitant
infections/diseases, severe malnutrition, or danger signs as
defined by WHO [3]. Pregnant women presenting with
symptoms of malaria (axillary temperature ≥37.5C or his-
tory of fever and no sign of danger or disease severity)
were also enrolled.
Samples collection
Standard operating procedures for sample collection
were provided to the study teams. At inclusion, a rapid
diagnostic test (Mal card™) has been performed to diag-
nose malaria and thick blood smear made to quantify
malaria parasites against 200 leucocytes. Parasite density
was calculated for each patient assuming an average of
8000 leucocytes per μl of blood. RDT specimens were
kept for further parasite DNA extraction.
Specimen processing
Extraction of parasite DNA
Parasite DNA was extracted from RDT cassettes. Briefly,
the cassette was broken and the nitrocellulose mem-
brane removed. The visible zones of blood migration on
the membrane were cut into small pieces with a scissor
and placed in labeled tubes. One ml of lysis solution
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added and mixed by vortex for 15 seconds. The samples
extracts were incubated for 30 minutes at room
temperature (mixed by vortex every 10 minutes for 15
seconds). Samples extracts were then centrifuged at 10
000rpm for 10 minutes. The supernatants were dis-
carded and pellets re-suspended into 50 ul of distilled
water. The samples were incubated at 90C for 10 min-
utes, mixed by vortex, and 8 000 rpm for 1 minute. The
supernatants which include parasite DNA, were
removed and conserved at −20C.
Plasmodium falciparum msp2 genotyping
Acknowledging that msp-2 gene is used by many studies as
a discriminatory marker for field isolates characterization
[12], it is here considered as a single genotyping marker.
Genotyping of falciparum parasite isolates was performed
with nested PCR assays based on the amplification of msp2
according to Koukouikila et al. [10]. Variable central block
2 was amplified to distinguish allelic families 3D7 and
FC27. The amplified PCR products were loaded on to 2%
agarose gel (SeaKem, Sigma, St. Louis, MO), subjected to
electrophoresis and DNA was visualized under ultraviolet
light and photographed to analyze size polymorphism in
each allelic family, assuming that one band represented one
amplified PCR fragment derived from a single copy of
P. falciparum MSP2 gene.
Distribution of P. falciparum msp2 allele types and
multiplicity of infection
The prevalence of the different msp2 alleles was deter-
mined as the presence of PCR products in the total num-
ber of msp2 amplified bands. The multiplicity of infection
(MOI) was defined as the mean number of P. falciparum
genotypes per infected individual. It was calculated as the
ratio of the total number of P. falciparummsp2 genotypes
and the number of PCR positive samples.
Statistical analysis
Data were double-entered by two clerks, entry discrep-
ancies cleared by supervisor and validated in Epi info
version 3.5.1 software by the biostatistician and analyzed
using SPSS version 16. Microscopy and PCR were used
as the standard references to calculate sensitivity and
specificity of different tests at selected health facilities.
The variable considered: diagnostic performance were
defined using the number of true positive (TP), number
of true negative (TN), number of false positive (FP) and
number of false positive (FP). The sensitivity of the test
was determined as Number of true positives/[Number of
true positives + number of false positives] × 100. The
specificity of the test was determined as Number of true
negatives/ Number of true negatives + number of false
positives] ×100.Positive predictive values (PPVs) and negative predict-
ive values (NPVs) were calculated as described by Iqbal
et al. [13].
McNemar-χ2 test was used to investigate any signifi-
cant differences between microscopy and RDT or PCR
and RDT. Fisher's Exact test was used to compare mal-
aria prevalence between health centers and also between
children and pregnant women. Differences were consid-
ered significant if p value<0.05.
The kappa value (κ), representing the proportion of
agreement beyond chance, was used to quantify the level
of agreement or concordance between both methods; a
kappa value of 0.21-0.60 was considered moderate agree-
ment, 0.61-0.80 good agreement and κ ≥ 0.8 was of high
concordance [14].
Results
Prevalence of malaria infection at the different health
facilities
A total of 3,290 children were recruited into the study
from four health facilities in Brazzaville and Pointe-
Noire (Table 1); out of which, 2,144 were recruited dur-
ing the transmission season of October to December
2011 Only P. falciparum species was detected by mi-
croscopy. Four-hundred and four (404) children had
malaria infection, representing 12% of consulting cases
and reflecting the number of children who received anti-
malarials. In Brazzaville, CSI Fleuve Congo which is
close to Congo river presented the highest malaria
prevalence in children: 29% (76/263) compared to 8%
(159/2037) and 19% (108/578) at the hospital Talangai
and CSI Intendance which are located on a hill. In
Pointe-Noire: Out of a total of 412 children, 61 were
found microscopy or TDR positive for Plasmodium
falciparum. The median age of children on consultation
at different health care facilities was similar (5 years).
Regarding pregnant women, microscopy was mostly
used (90/131 cases) and showed malaria prevalence in
pregnant women to be similar to that observed in chil-
dren under 15 years of age in all sites. In details, a total
of 750 pregnant women distributed as 737 and 13 were
recruited at Brazzaville and Pointe-Noire respectively
from October 2011 to February 2012. The mean age of
recruited women was 24 years in all selected sites. The
prevalence of P. falciparum infection in pregnant
women ranged from 8 to 24% for all health facilities
(Table 1). At the CSI Ndaka Sossou in Pointe –Noire,
the prevalence of asymptomatic malaria infections in
pregnant women represented 23% (3/13).
Quality control of laboratory techniques
CSI and CSI Ndaka Sossou preferentially utilized mi-
croscopy and RDT for the diagnosis of malaria respect-
ively. Because of this, both district centers were assessed
Table 1 Malaria positivity by RDTs at various health facilities in Brazzaville and Pointe-Noire during the study period
October 2011 to February 2012












Children< 15 yrs 2037 263 578 412 3290
Malaria cases 159 (8) 76 (29) 108 (19) 61 (15) 404 (12)
m+/RDT+ 80 27 28 59 194
m+/RDT- 79 49 80 2 210
Mean age years (SD) 5,78±8,68 6,02±13,62 5,34±3,32 6,20±3,89 -
Range (1–15) (1–15) (1–15) (1–15)
Pregnant women 259 143 335 13 750
Malaria cases 22 (8) 27 (19) 79 (24) 3 (23) 131 (17)
m+/RDT+ 17 6 15 3 41
m+/RDT- 5 21 64 0 90
Mean age years (SD) 24,36±7,69 26,83±14,16 24,06±4,78 26,39±2,76 -
Range (16–42) (16–39) (19–40) (21–36)
m+ microscopy positive; m- microscopy negative; RDT rapid diagnostic test.
M+/RDT+ both techniques used; m+/RDT- only microscopy used.
*significant difference (p=0.04) between malaria prevalence in children and pregnant women.
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lecular biology laboratory of the Faculty of Health
Sciences/University M. Ngouabi in Brazzaville as shown
in Table 2. Fifty matched RDT/thick blood smears at
CSI Intendance and 27 at Ndaka Sossou were randomly
selected and re-read at the reference lab (Table 3). A sig-
nificant difference in performances between the gold
standard PCR and RDT was observed at both centers
but no difference when microscopy was considered as
gold standard. Kappa values for concordance was mod-
erate (0.43 and 0.35) for microscopy at both health facil-
ities while RDT performance was good (0.88) at CSI
Intendance (Table 3).
P. falciparum multiplicity of infection, genetic diversity
and parasite densities in isolates from children in
Brazzaville and Pointe-Noire
The multiplicity of infection (MOI) referred as the mean
number of Plasmodium falciparum clones per infected
individual, genetic diversity and parasite densities were
determined for children consulting in Brazzaville and
Pointe-Noire health facilities. MOI was similar (about
1.7) in both health centers. The distribution of 3D7 and
FC27 allelic families of msp2 Plasmodium falciparumTable 2 Multiplicity of infection and msp-2genetic diversity in
attending CSI Intendance (Brazzaville) and Ndaka Sossou (Po
Health facility MOI Nb 3D7 fragments
(range size band in bp)
Brazzaville 1.6 5 (240–480)
Pointe-Noire 1.8 13 (300–500)
Nb of fragments = number of PCR fragments using 3D7 or FC27 allele-specific prim
Mean parasite density = parasite densities of children under five were considered.show the presence of 11 and 22 msp2 alleles in clinical
isolates from patients from Brazzaville (CSI Intendance)
and Pointe Noire (CSI ndaka Sossou) respectively The
genetic diversity was much higher in isolates from
Pointe-Noire and parasite densities higher in patients
from Brazzaville (Table 2).
Discussion
To bridge knowledge gaps due to limited data from the
Republic of Congo on the burden of malaria infection
and on utility of available diagnostic tools, the present
study documents the burden of uncomplicated malaria
and utility of laboratory diagnostics for malaria case
management at selected health facilities in Brazzaville
and Pointe-Noire, where RDTs and microscopes are
already provided. To the best of our knowledge, this is
the first study since change of National malaria treat-
ment policy in 2002.
The malaria prevalence of 9% reported in children
from two health districts in Northern part of the capital
is similar to that reported by Koukouikila et al. [10]
from Southern part. However malaria prevalence in chil-
dren living close to the river in Brazzaville and preva-
lence in Pointe-Noire reached 30% indicating variationsPlasmodium falciparum isolates from Congolese children
inte Noire) health facilities
Nb FC27 fragments
(range size band in bp)
Mean parasite density
(range) p/μl
6 (360–460) 87,480 (4000–108800)
9 (400–540) 2862 (438–8368)
ers.
Table 3 Microscopy and RDT quality control of two





N P κ N P κ
N 41 4 0.43 45 1 0.88




N P κ N P κ
N 20 1 0.35 20 1 0.35
P 4 2 4 2
The kappa value (κ).
N negative, P positive.
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approaches to control. Despite lack of comparative data
for malaria prevalence in pregnant women, the observed
15% prevalence is high and of concern considering that
the policy of intermittent preventive treatment with
sulfadoxine/pyrimethamine (SP) during pregnancy (SP-
IPTp) is implemented throughout the country. Pregnant
women were enrolled irrespective of their SP-IPTp sta-
tus. It is therefore possible that SP-IPTp may not be ef-
fective, strengthening need for the re-assessment of this
control strategy.
It is interesting noting that at two health centers where
quality control for microscopy and interpretation of
RDT were done, utility of RDTs as a diagnostic tool was
poor particularly in Brazzaville even though laboratory
technicians knew. It is unlikely that poor adherence was
due to lack of experience. Informally, many technicians
were reluctant to use RDTs because their availability was
not sustainable and microscope slides were still abun-
dant. Studies conducted in Tanzania [15-17] correctly
stressed the fact that the new strategy of malaria con-
firmation before treatment should be accompanied by
systems strengthening to better attain the goal of im-
proving health care. Microscopy reading is time con-
suming if properly done and it has been reported by
many studies that it could be less sensitive than RDT
[18]. It is highly possible that Congolese patients have
long been treated inappropriately. This study confirms
that apart from improving health systems through
strengthening logistics, there is also need to invest in
manpower development/training and monitoring assess-
ment of processes for implementation.
The genetic diversity among Plasmodium falciparum
field isolates in Northern Brazzaville and in Pointe-Noire
reveals limited and high genetic diversity but not sur-
prising considering that CSI Intendance is located on a
hill. In comparison the genetic diversity in Southern part
of Brazzaville where malaria transmission is intense, the
MOI and genetic diversity [10] was higher. The geneticdiversity in Pointe Noire remained high despite known
introduced intervention tools suggesting lack of impact.
However, this might be explained by differences in
laboratory techniques that were used in the two studies
to determine genetic diversity [19]. Unfortunately, ento-
mological studies have not been carried out in these
areas to determine the current level/intensity of malaria
transmission. In earlier studies conducted in Southern
area of Brazzaville, the MOI was 2.2 in clinical isolates
[9] and reduced to 1.6 after introduction of ACTs. Simi-
lar MOI is now reported from the Northern part of
Brazzaville and from Pointe-noire. A similar trend in re-
duction of parasite densities is observed from Southern
part of Brazzaville when current findings are compared
to those published earlier [19-21]. This may reflect an
impact of the ACTs and high use of insecticide-treated
nets within the country. However, the genetic diversity
remains unchanged suggesting that introduced interven-
tions do not eliminate specific allelic forms.
We recommend that laboratory technicians should be
trained on the importance and advantages of using RDTs
compared to microscopy such as simplicity, patient time
saved and its modest reliability. Indeed, malaria is over-
diagnosed and over-treated in many African countries
through clinical diagnosis only, while other clinicians do
not honor laboratory results [22-24]. While it is clear
that behavior change is a lengthy process, the notion
that health workers were rather skeptical about a steady
supply of RDTs by the state sounds lame.
Conclusion
The study has shown the need to provide a targeted
training to health workers to enhance acceptability of
RDTs and improve quality of care. It also revealed that
MOI and parasite densities in clinical Congolese isolates
from the two main cities are low and the P.falciparum
genetic diversity remains stable.
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